Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Heidemann

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[An abnormal lipid profile: when to perform additional research for a genetic cause?]Britt E Heidemann, Monique Prinssen, A D Marais, et al.
BMJ Case Reports|November 24, 2022
Clinical heterogeneity in monogenic chylomicronaemiaBritt E Heidemann, Remy H H Bemelmans, A David Marais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer SocietyK Mross, C Bohn, L Edler, et al.
International Journal of Cardiology|August 19, 2020
The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular diseaseBritt E Heidemann, Charlotte Koopal, Michiel L Bots, et al.
Deutsche Medizinische Wochenschrift (1946)|October 12, 2012
[Symptom-oriented follow-up of early breast cancer compared to intensive surveillance. Results of a prospective multicentre study: update and 10-year overall survival]S Bornhak, E Heidemann, C Meisner, et al.
Onkologie|February 1, 1990
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancerE Heidemann, B Steinke, J Hartlapp, et al.
Onkologie|February 1, 1989
[Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results]B Steinke, A Kraft, H M Reinold, et al.
Atherosclerosis|April 23, 2021
Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohortsBritt E Heidemann, Frank J Wolters, Maryam Kavousi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOPB Steinke, K Bross, H M Reinold, et al.
Anticancer Research|December 29, 2010
Clinical impacts of histological subtyping primary breast cancerP Fritz, S Klenk, S Goletz, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[An abnormal lipid profile: when to perform additional research for a genetic cause?]Britt E Heidemann, Monique Prinssen, A D Marais, et al.
BMJ Case Reports|November 24, 2022
Clinical heterogeneity in monogenic chylomicronaemiaBritt E Heidemann, Remy H H Bemelmans, A David Marais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer SocietyK Mross, C Bohn, L Edler, et al.
International Journal of Cardiology|August 19, 2020
The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular diseaseBritt E Heidemann, Charlotte Koopal, Michiel L Bots, et al.
Deutsche Medizinische Wochenschrift (1946)|October 12, 2012
[Symptom-oriented follow-up of early breast cancer compared to intensive surveillance. Results of a prospective multicentre study: update and 10-year overall survival]S Bornhak, E Heidemann, C Meisner, et al.
Onkologie|February 1, 1990
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancerE Heidemann, B Steinke, J Hartlapp, et al.
Onkologie|February 1, 1989
[Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results]B Steinke, A Kraft, H M Reinold, et al.
Atherosclerosis|April 23, 2021
Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohortsBritt E Heidemann, Frank J Wolters, Maryam Kavousi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOPB Steinke, K Bross, H M Reinold, et al.
Anticancer Research|December 29, 2010
Clinical impacts of histological subtyping primary breast cancerP Fritz, S Klenk, S Goletz, et al.
Pageof 7